top of page


The Role of Exercise in Alzheimer’s Disease Treatment and Prevention
by Zaid Firas , March 2025 As Alzheimer’s disease (AD) continues to affect millions worldwide, scientists are uncovering a powerful new...
Mar 21, 20256 min read
The Pivotal Role of Gut Microbiota in Alzheimer's Disease Progression and Prevention
The human gut microbiota, comprised of trillions of microorganisms existing symbiotically within the gastrointestinal tract, plays a vital role in maintaining gut and neurological health by regulating homeostasis through the gut-brain axis. Recent studies have shown that an imbalance or alteration of the composition of gut microbiota, or gut dysbiosis, is linked to the aggregation of Aβ, the development of tau proteins, and the occurrence of neuroinflammation and oxidative st
Mar 30, 20243 min read
The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
The article "The Role of Microglia in the Spread of Tau: Relevance for Tauopathies" by Juan R. Perea et al. provides significant insights into Alzheimer's disease (AD) research, particularly focusing on the role of microglia in the disease's progression. In highly industrialized areas there has been an increasing number of individuals suffering from gut microbiota dysbiosis (a decrease in the diversity of microorganism characteristics and an increase in pro-inflammatory spec
Feb 29, 20241 min read
Natural inhibitors as effective antagonists for Tau and β-amyloid in Alzheimer’s rat model
This study by Mervat et al. aimed to evaluate the potential of aqueous extracts from Rosemary (Rosmarinus officinalis L.) and Saffron (Crocus sativus L.) individually and in combination as avenues to work against tau and β-amyloid in an Alzheimer's rat model. In Alzheimer's disease, β-amyloid proteins aggregate to form plaques outside neurons, while tau works almost in the opposite, forming protein plaques within neurons. These protein formations are associated with many diff
Feb 28, 20242 min read
Lifestyle intervention to prevent Alzheimer’s disease
Alzheimer’s disease (AD) is considered to be one of the most common degenerative diseases, largely affecting the elderly population. This disease negatively impacts memory and cognition due to the accumulation of beta-amyloid plaques and neurofibrillary tangles. While there is no cure, there are ways to lower risk factors, as a healthy lifestyle can be a preventive measure against AD. A previous study found that living alone and not having a romantic partner can increase the
Feb 28, 20242 min read
Exercise Increases Brain-Derived Neurotrophic Factor Levels in Older Adults to Improve Cognitive Function in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most prominent form of dementia caused by aging (Choi et al., 2018). This disease negatively impacts the brain, causing cognitive deficits, degeneration of neurons, and brain inflammation. Alzheimer's patients have reduced brain-derived neurotrophic factor (BDNF) and other proteins that promote neuronal function. However, numerous studies have determined that physical exercise promotes neurotrophin levels and increases growth factors, including
Feb 28, 20244 min read
Potential New Amyloid-β-Targeting Therapeutic Pathway
An article published in Nature Aging in September 2023 by a research group (Lau et al.) from Hong Kong identified a potential new target for an Alzheimer’s treatment capable of slowing the progression of the disease.1 In Alzheimer’s disease (AD), the amyloid-β protein aggregates to form senile plaques which contribute to the worsening of the disease. Microglia, which are immune cells of the nervous system, have an essential role to clear these plaques by engulfing and degradi
Dec 22, 20232 min read
Review: Trial of Solanezumab in Preclinical Alzheimer’s Disease
This article by Sperling et al. looked at a potential treatment, solanezumab, for Alzheimer's disease. Solanezumab, a monoclonal antibody, is designed to target a specific substance called amyloid in the brain, which is believed to be linked to Alzheimer's. Amyloid is an abnormal protein that generates in the brain that integers with memory neuron signalling. The study involved those aged 65 and 85 who had elevated levels of amyloid in their brains but did not show any signs
Dec 22, 20232 min read
bottom of page
